Join MAPS on LinkedIn to further build your professional connections within Medical Affairs through our Company and Group Pages.
Follow us on Twitter and say abreast of MAPS activities and key issues for Medical Affairs professionals.
Charlotte Kremer, MD, MBA
EVP and Head of Medical Affairs
Astellas Pharma Inc.
Mary Alice Dwyer, PharmD
VP, Global Medical Excellence, Global Medical Affairs
Charlotte Raabe-Hielscher, MS
Sr. Director, Human Resources
Over the last decade, the Medical Affairs function has increasingly become a critical strategic partner within the Pharmaceutical and Medical Device industry. Consequently, the scope and expectations of Medical Affairs personnel has increased significantly, with the function evolving from a reactive and more passive team, to a more strategic and proactive capability within the organization. It is expected that external changes will drive this evolution even further.
While in the past, Medical Affairs departments in pharma may have been the home to physicians, pharmacists and scientists who responded to questions and shared their knowledge upon request, these days Medical Affairs professionals are expected to understand the scientific and clinical needs of external customers, to create and execute Medical Affairs plans, to be proactive business partners to internal stakeholders such as the Clinical Development and the Commercial organizations and ultimately play a leadership role in creating and communicating the core value driver for patients and physicians through advancing their understanding of safe and appropriate use of treatments.
Medical Affairs professionals have been successful in capturing this momentum, and have further shaped and evolved the function appropriately to meet these new expectations. However, with this evolution also come challenges; the capabilities and skills that were sufficient in the past, such as clinical experience and medical knowledge, will no longer be sufficient to support these new expectations.
What are these newly required competencies? Do we, as Medical affairs professionals, have consensus of what these are? How do we align our expertise and experiences to address the external changes in the digital space, in data generation in the real world, in an evolving dialogue with patients? How do we develop these in ourselves, in our respective organizations? How do we grow and develop the talent in Medical Affairs to be ready to meet the new expectations?
This workshop will review the evolution of Medical Affairs, will introduce and discuss the capabilities required for success and will present some real-life examples of how certain pharma companies have taken this on board through Learning and Development targeted for Medical Affairs.
Workshop attendees will be able to:
[mepr-show if=”rule: 4078″]
[mepr-hide if=”rule: 4078″]
Your subscription has expired. To view this content, please visit your account page to purchase a new subscription.
Please login or purchase a membership to view this content.